These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 38514330)
1. [The diagnostic value of genetic testing in familial hypercholesterolemia in patients with premature myocardial infarction]. Cui YX; Song JX; Li ZY; Li SF; Liu CF; Chen H Zhonghua Xin Xue Guan Bing Za Zhi; 2024 Mar; 52(3):281-285. PubMed ID: 38514330 [No Abstract] [Full Text] [Related]
2. Prevalence of familial hypercholesterolemia in patients with premature myocardial infarction. Cui Y; Li S; Zhang F; Song J; Lee C; Wu M; Chen H Clin Cardiol; 2019 Mar; 42(3):385-390. PubMed ID: 30637778 [TBL] [Abstract][Full Text] [Related]
3. Effects of familial hypercholesterolemia-associated genes on the phenotype of premature myocardial infarction. Lee C; Cui Y; Song J; Li S; Zhang F; Wu M; Li L; Hu D; Chen H Lipids Health Dis; 2019 Apr; 18(1):95. PubMed ID: 30971288 [TBL] [Abstract][Full Text] [Related]
4. Cascade Screening for Familial Hypercholesterolemia in South Africa: The Wits FIND-FH Program. Raal FJ; Bahassi EM; Stevens B; Turner TA; Stein EA Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2747-2755. PubMed ID: 32878475 [TBL] [Abstract][Full Text] [Related]
5. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores. Miserez AR; Martin FJ; Spirk D Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060 [TBL] [Abstract][Full Text] [Related]
6. Screening and verifying the mutations in the LDLR and APOB genes in a Chinese family with familial hypercholesterolemia. Lv X; Wang C; Liu L; Yin G; Zhang W; Abdu FA; Shi T; Zhang Q; Che W Lipids Health Dis; 2023 Oct; 22(1):175. PubMed ID: 37853441 [TBL] [Abstract][Full Text] [Related]
8. Spectrum of mutations of familial hypercholesterolemia in the 22 Arab countries. Alhababi D; Zayed H Atherosclerosis; 2018 Dec; 279():62-72. PubMed ID: 30415195 [TBL] [Abstract][Full Text] [Related]
9. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia. Grenkowitz T; Kassner U; Wühle-Demuth M; Salewsky B; Rosada A; Zemojtel T; Hopfenmüller W; Isermann B; Borucki K; Heigl F; Laufs U; Wagner S; Kleber ME; Binner P; März W; Steinhagen-Thiessen E; Demuth I Atherosclerosis; 2016 Oct; 253():88-93. PubMed ID: 27596133 [TBL] [Abstract][Full Text] [Related]
17. Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia: Implications for clinical diagnosis. Di Costanzo A; Minicocci I; D'Erasmo L; Commodari D; Covino S; Bini S; Ghadiri A; Ceci F; Maranghi M; Catapano AL; Gazzotti M; Casula M; Montali A; Arca M J Clin Lipidol; 2021; 15(6):822-831. PubMed ID: 34756585 [TBL] [Abstract][Full Text] [Related]
18. Targeted Genetic Analysis in a Chinese Cohort of 208 Patients Related to Familial Hypercholesterolemia. Wang H; Yang H; Liu Z; Cui K; Zhang Y; Zhang Y; Zhao K; Yin K; Li W; Zhou Z J Atheroscler Thromb; 2020 Dec; 27(12):1288-1298. PubMed ID: 32759540 [TBL] [Abstract][Full Text] [Related]
19. Proprotein convertase subtilisin/kexin 9 V4I variant with LDLR mutations modifies the phenotype of familial hypercholesterolemia. Ohta N; Hori M; Takahashi A; Ogura M; Makino H; Tamanaha T; Fujiyama H; Miyamoto Y; Harada-Shiba M J Clin Lipidol; 2016; 10(3):547-555.e5. PubMed ID: 27206942 [TBL] [Abstract][Full Text] [Related]
20. Familial hypercholesterolemia in China half a century: A review of published literature. Peng J; Wu X; Wang S; Zhang S; Wang X; Liu Z; Hong J; Ye P; Lin J Atheroscler Suppl; 2019 Mar; 36():12-18. PubMed ID: 30876527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]